You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | 0.0% | -5,078.0% |
| ROCE | 0.0% |
| Latest | Forecast | |
|---|---|---|
| P/E | -5.7 | 0.0 |
| PEG | 0.0 | -999,999.0 |
| Price / Revenue | 0.0 | 162.7 |
| Price / Book value | 2.5 |
| Latest | Forecast | |
|---|---|---|
| Revenue | n/a | 0.0% |
| PBT | 0.0% | n/a |
| EPS | 0.0% | 42.5% |
| DPS | n/a | 0.0% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2016-12-31 | n/a | -1.45 | -4.00p | 0.0 | 0.0 | n/a | n/a | 0.0% |
| 2017-12-31 | n/a | -3.21 | -8.40p | -17.0 | 0.0 | n/a | n/a | 0.0% |
| 2018-12-31 | n/a | -6.01 | -11.90p | -5.2 | 0.0 | n/a | n/a | 0.0% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2019-12-31 | 0.18 | -9.31 | -19.60p | 0.0 | n/a | 0% | 0.00p | 0.0% |
| 2019-12-31 | 0.18 | -9.31 | -19.60p | 0.0 | n/a | 0% | 0.00p | 0.0% |
| 2019-12-31 | 0.18 | -9.31 | -19.60p | 0.0 | n/a | 0% | 0.00p | 0.0% |
| 2020-12-31 | 0.08 | -4.37 | -8.09p | 0.0 | n/a | 0% | 0.00p | 0.0% |
| 2020-12-31 | 0.08 | -4.37 | -8.09p | 0.0 | n/a | 0% | 0.00p | 0.0% |
| 2020-12-31 | 0.08 | -4.37 | -8.09p | 0.0 | n/a | 0% | 0.00p | 0.0% |
| Destiny Pharma 'well funded' despite wider loss Sharecast News | 09 Apr |
|---|---|
| Destiny Pharma sees success in latest trial of XF-73 nasal gel Sharecast News | 28 Jan |
| Destiny Pharma leaps on £1.6m grant and UK-China collaboration Sharecast News | 25 Jan |
| Grant of Options | 04-Jun-19 14:40 |
|---|---|
| Result of AGM | 04-Jun-19 12:08 |
| Appointment of NOMAD and Joint Broker | 09-May-19 14:07 |
| Posting of Annual Report and Notice of AGM | 29-Apr-19 14:29 |